0001104659-21-147745.txt : 20211208 0001104659-21-147745.hdr.sgml : 20211208 20211208182151 ACCESSION NUMBER: 0001104659-21-147745 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211108 FILED AS OF DATE: 20211208 DATE AS OF CHANGE: 20211208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Booker Harriet CENTRAL INDEX KEY: 0001723978 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11993 FILM NUMBER: 211479804 MAIL ADDRESS: STREET 1: C/O BIOSCRIP, INC. STREET 2: 1600 BROADWAY, SUITE 700 CITY: DENVER STATE: CO ZIP: 80202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Option Care Health, Inc. CENTRAL INDEX KEY: 0001014739 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 050489664 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3000 LAKESIDE DR STREET 2: SUITE 300N CITY: BANNOCKBURN STATE: IL ZIP: 60015 BUSINESS PHONE: 312 940 2443 MAIL ADDRESS: STREET 1: 3000 LAKESIDE DR STREET 2: SUITE 300N CITY: BANNOCKBURN STATE: IL ZIP: 60015 FORMER COMPANY: FORMER CONFORMED NAME: BioScrip, Inc. DATE OF NAME CHANGE: 20050314 FORMER COMPANY: FORMER CONFORMED NAME: MIM CORP DATE OF NAME CHANGE: 19960516 4 1 tm2134952d1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-11-08 0 0001014739 Option Care Health, Inc. OPCH 0001723978 Booker Harriet C/O OPTION CARE HEALTH, INC. 3000 LAKESIDE DRIVE, #300N BANNOCKBURN IL 60015 0 1 0 0 CHIEF OPERATING OFFICER Common Stock, par value $0.0001 2021-11-08 4 M 0 6000 A 131974 D Common Stock, par value $0.0001 2021-11-08 4 S 0 6000 27.93 D 125974 D Common Stock, par value $0.0001 2021-12-06 4 M 0 6000 A 131974 D Common Stock, par value $0.0001 2021-12-06 4 S 0 6000 24.81 D 125974 D Employee Stock Option (Right to Buy) 10.12 2021-11-08 4 M 0 6000 0 D Common Stock, par value $0.0001 6000 29249 D Employee Stock Option (Right to Buy) 10.12 2021-12-06 4 M 0 6000 0 D Common Stock, par value $0.0001 6000 23249 D These stock options were granted on November 28, 2017, and vested and became exercisable in three equal installments commencing on the first anniversary of the grant date. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Table I, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $27.91 to $27.98. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price. / s/ Clifford E. Berman, by power of attorney 2021-12-08